List of Excipients in API ertugliflozin and sitagliptin
✉ Email this page to a colleague
Excipients in NDA-approved (novel) drugs containing ertugliflozin and sitagliptin
| Company | Tradename | Ingredient | NDC | Excipient | Potential Generic Entry |
|---|---|---|---|---|---|
| Merck Sharp & Dohme LLC | STEGLUJAN | ertugliflozin and sitagliptin | 0006-5367 | ANHYDROUS DIBASIC CALCIUM PHOSPHATE | 2030-10-21 |
| Merck Sharp & Dohme LLC | STEGLUJAN | ertugliflozin and sitagliptin | 0006-5367 | CARNAUBA WAX | 2030-10-21 |
| Merck Sharp & Dohme LLC | STEGLUJAN | ertugliflozin and sitagliptin | 0006-5367 | CELLULOSE, MICROCRYSTALLINE | 2030-10-21 |
| >Company | >Tradename | >Ingredient | >NDC | >Excipient | >Potential Generic Entry |
Detailed excipient profiles for ertugliflozin and sitagliptin
Excipient focus: ANHYDROUS DIBASIC CALCIUM PHOSPHATE
ertugliflozin and sitagliptin drug variants containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | ertugliflozin and sitagliptin | 0006-5367 |
| >Company | >Ingredient | >NDC |
ertugliflozin and sitagliptin drug variants not containing ANHYDROUS DIBASIC CALCIUM PHOSPHATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CARNAUBA WAX
ertugliflozin and sitagliptin drug variants containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | ertugliflozin and sitagliptin | 0006-5367 |
| >Company | >Ingredient | >NDC |
ertugliflozin and sitagliptin drug variants not containing CARNAUBA WAX
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CELLULOSE, MICROCRYSTALLINE
ertugliflozin and sitagliptin drug variants containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | ertugliflozin and sitagliptin | 0006-5367 |
| >Company | >Ingredient | >NDC |
ertugliflozin and sitagliptin drug variants not containing CELLULOSE, MICROCRYSTALLINE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: CROSCARMELLOSE SODIUM
ertugliflozin and sitagliptin drug variants containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | ertugliflozin and sitagliptin | 0006-5367 |
| >Company | >Ingredient | >NDC |
ertugliflozin and sitagliptin drug variants not containing CROSCARMELLOSE SODIUM
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE RED
ertugliflozin and sitagliptin drug variants containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | ertugliflozin and sitagliptin | 0006-5367 |
| >Company | >Ingredient | >NDC |
ertugliflozin and sitagliptin drug variants not containing FERRIC OXIDE RED
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERRIC OXIDE YELLOW
ertugliflozin and sitagliptin drug variants containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | ertugliflozin and sitagliptin | 0006-5367 |
| >Company | >Ingredient | >NDC |
ertugliflozin and sitagliptin drug variants not containing FERRIC OXIDE YELLOW
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: FERROSOFERRIC OXIDE
ertugliflozin and sitagliptin drug variants containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | ertugliflozin and sitagliptin | 0006-5367 |
| >Company | >Ingredient | >NDC |
ertugliflozin and sitagliptin drug variants not containing FERROSOFERRIC OXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYDROXYPROPYL CELLULOSE
ertugliflozin and sitagliptin drug variants containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | ertugliflozin and sitagliptin | 0006-5367 |
| >Company | >Ingredient | >NDC |
ertugliflozin and sitagliptin drug variants not containing HYDROXYPROPYL CELLULOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: HYPROMELLOSE
ertugliflozin and sitagliptin drug variants containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | ertugliflozin and sitagliptin | 0006-5367 |
| >Company | >Ingredient | >NDC |
ertugliflozin and sitagliptin drug variants not containing HYPROMELLOSE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: MAGNESIUM STEARATE
ertugliflozin and sitagliptin drug variants containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | ertugliflozin and sitagliptin | 0006-5367 |
| >Company | >Ingredient | >NDC |
ertugliflozin and sitagliptin drug variants not containing MAGNESIUM STEARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: PROPYL GALLATE
ertugliflozin and sitagliptin drug variants containing PROPYL GALLATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | ertugliflozin and sitagliptin | 0006-5367 |
| >Company | >Ingredient | >NDC |
ertugliflozin and sitagliptin drug variants not containing PROPYL GALLATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: SODIUM STEARYL FUMARATE
ertugliflozin and sitagliptin drug variants containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | ertugliflozin and sitagliptin | 0006-5367 |
| >Company | >Ingredient | >NDC |
ertugliflozin and sitagliptin drug variants not containing SODIUM STEARYL FUMARATE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Excipient focus: TITANIUM DIOXIDE
ertugliflozin and sitagliptin drug variants containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| Merck Sharp & Dohme LLC | ertugliflozin and sitagliptin | 0006-5367 |
| >Company | >Ingredient | >NDC |
ertugliflozin and sitagliptin drug variants not containing TITANIUM DIOXIDE
| Company | Ingredient | NDC |
|---|---|---|
| >Company | >Ingredient | >NDC |
Make Better Decisions: Try a trial or see plans & pricing
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
DrugPatentWatch Alternatives
LOE / Generic Entry Opportunies 2025 - 2026
NCE-1 Patent Challenge Dates 2025 - 2026
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2025, www.DrugPatentWatch.com.
See Primary Research Papers Citing DrugPatentWatch